1. Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2. Pratico D Dogne J. Selective COX-2 inhibitors development in cardiovascular medicine. Circulation. In press.
3. Brophy J. Hot Topic: Cyclooxygenase-2 inhibition and coronary risk. Available at: McGraw-Hill’s AccessMedicine Harrison’s Online Updates 2005. Accessed March 25 2005.
4. Statement of Sandra Kweder MD Deputy Director Office of New Drugs Center for Drug Evaluation and Research US Food and Drug Administration. Washington DC: Committee on Finance United States Senate; November 18 2004. Available at: http://www.fda/gov/ola/2004/vioxx1118.html. Accessed December 31 2004.
5. US Food and Drug Administration Center for Drug Evaluation and Research Public Health Advisory. Non-steroidal anti-inflammatory drug products (NSAIDS). Available at: http://www.fda.gov/cder/drug/advisory/nsaids.htm. Accessed January 19 2005.